Dividend Stocks: Research pays off for Pfizer

Dividend Stocks: Research pays off for Pfizer

The leading drugmaker continues to use share buybacks to increase shareholder value as it bolsters its revenue and earnings.

PFIZER INC. (New York symbol PFE; www.pfizer.com) is one of the world’s leading prescription drugmakers. Its top-selling brands include Lyrica (epilepsy), Celebrex (arthritis pain), Prevnar (pneumonia)… Read More

Buy these bond ETFs for stable income

Buy these bond ETFs for stable income

These two bond ETFs offer exposure to quality holdings with low-fees, but they’re best left to investors who need stable income and really want to hold bonds.
The Bank of Canada will likely hold interest rates steady for all of 2017. That’s because low prices for… Read More

What is Pat’s commentary for the week of May 2, 2017

Dear Inner Circle Member,
Today, many households and even some individuals have five or 10 separate investment accounts. These accounts may include RRSPs (regular and spousal), TFSAs and other registered accounts, personal and joint accounts, corporate accounts, LIRAs from past employment, children’s accounts, trust accounts and… Read More

Growth Stocks: Johnson & Johnson plans for a growth spurt

Growth Stocks: Johnson & Johnson plans for a growth spurt

Both revenue and earnings continue to grow for this leading maker of prescription drugs and consumer products. But still, there are risks.
JOHNSON & JOHNSON (symbol JNJ on New York; www.jnj.com) operates through three major businesses:
Pharmaceutical (47% of revenue) makes anti-infective, antipsychotic, contraceptive, dermatological and gastrointestinal… Read More

Asset sale cuts debt for Mitel Networks

Asset sale cuts debt for Mitel Networks

This tech company is now focused on its core communications business following the sale of a major division and the injection of cash to pay down its debt. 
MITEL NETWORKS (Toronto symbol MNW; www.mitel.ca) makes technology that integrates landlines and mobile phones. The company also offers… Read More